Home » Fischer's MammoTest Cleared by FDA for Brachytherapy Platform
Fischer's MammoTest Cleared by FDA for Brachytherapy Platform
Fischer Imaging recently received FDA clearance for use of the MammoTest Breast Biopsy System as a platform for interstitial breast brachytherapy. Developed by Robert Kuske, professor of radiation oncology at the University of Arizona, Interstitial Brachytherapy involves the precise, X-ray guided insertion of catheters to irradiate and control malignant tumors in the breast using the MammoTest digital imaging system.
Applied Radiology Online (http://www.appliedradiology.com//news/news.asp?Id=547&ThreadID=)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May